Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

Positive preliminary outcomes were reported for the first leukemia patient treated with Ossium Health's organ donor bone ...

Davis is able to focus on different numbers now. A linebacker, Davis ranks third on the team with 12 tackles. Last week, ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

On Friday, groups of preschoolers cycled Lake Havasu High School’s hallways for childhood cancer. The event is part of the ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...